Streptophage® (Solution) Instructions for Use
Marketing Authorization Holder
Microgen NPO, JSC (Russia)
ATC Code
V03A (Other therapeutic agents)
Dosage Form
| Streptophage® | Solution for oral, topical and external use: bottle 20 ml 4 or 10 pcs., 100 ml 1 pc. |
Dosage Form, Packaging, and Composition
Solution for oral, topical and external use as a transparent liquid of yellow color of varying intensity, a greenish tint is possible.
| 1 ml | |
| Streptococcal bacteriophage | Up to 1 ml |
* sterile purified filtrate of phage lysates of bacteria of the genus Streptococcus (with activity according to Appelman – not less than 10-5)
Excipients : preservative 8-hydroxyquinoline sulfate monohydrate (8-hydroxyquinoline sulfate – 0.0001 g/ml, calculated content).
20 ml – glass bottles (4) – cardboard packs.
20 ml – glass bottles (10) – cardboard packs.
100 ml – glass bottles (1) – cardboard packs.
Clinical-Pharmacological Group
Immunobiological drug – bacteriophage
Pharmacological Action
It has the ability to specifically lyse Streptococcus bacteria.
Indications
Treatment and prevention of diseases caused by Streptococcus bacteria as part of complex therapy: diseases of the ear, throat, nose, respiratory tract and lungs (inflammation of the sinuses, middle ear, tonsillitis, pharyngitis, laryngitis, tracheitis, bronchitis, pneumonia, pleurisy); surgical infections (wound suppuration, burns, abscess, phlegmon, boils, carbuncles, hidradenitis, panaritium, paraproctitis, mastitis, bursitis, osteomyelitis); urogenital infections (urethritis, cystitis, pyelonephritis, colpitis, endometritis, salpingo-oophoritis); enteral infections (gastroenterocolitis, cholecystitis), intestinal dysbiosis; generalized septic diseases; purulent-inflammatory diseases of newborns (including omphalitis, pyoderma, conjunctivitis, gastroenterocolitis, sepsis); other diseases caused by streptococci.
For prophylactic purposes, it is used for the treatment of postoperative and freshly infected wounds, as well as for the prevention of nosocomial infections for epidemic indications.
ICD codes
| ICD-10 code | Indication |
| A04 | Other bacterial intestinal infections |
| A09 | Other and unspecified gastroenteritis and colitis of infectious origin |
| A40 | Streptococcal sepsis |
| B95 | Streptococcus and Staphylococcus as the cause of diseases classified to other headings |
| H66 | Suppurative and unspecified otitis media |
| J01 | Acute sinusitis |
| J02 | Acute pharyngitis |
| J03 | Acute tonsillitis |
| J04 | Acute laryngitis and tracheitis |
| J13 | Pneumonia due to Streptococcus pneumoniae |
| J15 | Bacterial pneumonia, not elsewhere classified |
| J20 | Acute bronchitis |
| J31.0 | Chronic rhinitis (including ozaena, atrophic and hypertrophic rhinitis) |
| J31.2 | Chronic pharyngitis |
| J32 | Chronic sinusitis |
| J35.0 | Chronic tonsillitis |
| J37 | Chronic laryngitis and laryngotracheitis |
| J42 | Unspecified chronic bronchitis |
| J85 | Abscess of lung and mediastinum |
| J86 | Pyothorax (pleural empyema) |
| K52.9 | Noninfective gastroenteritis and colitis, unspecified |
| K61 | Abscess of anal and rectal regions |
| K63.8 | Other specified diseases of intestine |
| K81.0 | Acute cholecystitis |
| K81.1 | Chronic cholecystitis |
| L02 | Cutaneous abscess, furuncle and carbuncle |
| L03 | Cellulitis |
| L73.2 | Hidradenitis suppurativa |
| M70 | Soft tissue disorders related to use, overuse, and pressure |
| M71 | Other bursopathies |
| M86 | Osteomyelitis |
| N10 | Acute tubulointerstitial nephritis (acute pyelonephritis) |
| N11 | Chronic tubulointerstitial nephritis (chronic pyelonephritis) |
| N30 | Cystitis |
| N34 | Urethritis and urethral syndrome |
| N61 | Inflammatory diseases of the breast |
| N70 | Salpingitis and oophoritis |
| N71 | Inflammatory disease of uterus, excluding cervix (including endometritis, myometritis, metritis, pyometra, uterine abscess) |
| N72 | Inflammatory disease of cervix uteri (including cervicitis, endocervicitis, exocervicitis) |
| N73.5 | Unspecified female pelvic peritonitis |
| N76 | Other inflammatory diseases of vagina and vulva |
| O91 | Infections of the breast associated with childbirth |
| P36 | Bacterial sepsis of newborn |
| P38 | Omphalitis of newborn with or without mild hemorrhage |
| P39.1 | Neonatal conjunctivitis and dacryocystitis |
| P39.4 | Neonatal skin infection |
| P39.8 | Other specified infections specific to the perinatal period |
| T30 | Burns and corrosions of unspecified body region |
| T79.3 | Posttraumatic wound infection, not elsewhere classified |
| ICD-11 code | Indication |
| 1A01 | Intestinal infection caused by other Vibrio species |
| 1A03.Z | Intestinal infections caused by Escherichia coli, unspecified |
| 1A0Z | Bacterial intestinal infections, unspecified |
| 1A40.Z | Infectious gastroenteritis or colitis, unspecified |
| 1B70.1 | Streptococcal cellulitis of the skin |
| 1B70.2 | Staphylococcal cellulitis of the skin |
| 1B70.Z | Bacterial cellulitis or lymphangitis caused by unspecified bacterium |
| 1B75.0 | Furuncle |
| 1B75.1 | Carbuncle |
| 1B75.2 | Furunculosis |
| 1B75.3 | Pyogenic skin abscess |
| 1G40 | Sepsis without septic shock |
| AA9Z | Unspecified suppurative otitis media |
| CA01 | Acute rhinosinusitis |
| CA02.Z | Acute pharyngitis, unspecified |
| CA03.Z | Acute tonsillitis, unspecified |
| CA05 | Acute laryngitis or tracheitis |
| CA09.0 | Chronic rhinitis |
| CA09.2 | Chronic pharyngitis |
| CA0A.Z | Chronic rhinosinusitis, unspecified |
| CA0F.Y | Other specified chronic diseases of the palatine tonsils and adenoids |
| CA0G | Chronic laryngitis or laryngotracheitis |
| CA20.1Z | Chronic bronchitis, unspecified |
| CA40.07 | Pneumonia due to Streptococcus pneumoniae |
| CA40.0Z | Bacterial pneumonia, unspecified |
| CA42.Z | Acute bronchitis, unspecified |
| CA43.Z | Abscess of lung or mediastinum, unspecified |
| CA44 | Pyothorax |
| DA90.0 | Syndromic diarrhea |
| DA92.1 | Pneumatosis intestinalis of the small intestine |
| DA98.Z | Polyps of small intestine, unspecified |
| DB31.1 | Pneumatosis of the colon |
| DB36.Z | Certain infections of the colon, unspecified |
| DB70.0Z | Abscess of anal and rectal region, unspecified |
| DC12.0Z | Acute cholecystitis, unspecified |
| DC12.1 | Chronic cholecystitis |
| DE2Z | Diseases of the digestive system, unspecified |
| ED92.0 | Hidradenitis suppurativa |
| EH1Z | Neonatal infection of the skin, unspecified |
| FB50.1 | Bursitis associated with use, overuse or pressure |
| FB50.Z | Bursitis, unspecified |
| FB84.Z | Osteomyelitis or osteitis, unspecified |
| GA00 | Vulvitis |
| GA01.Z | Inflammatory diseases of uterus, except cervix, unspecified |
| GA02.Z | Unspecified vaginitis |
| GA05.2 | Unspecified pelvic peritonitis in women |
| GA07.Z | Salpingitis and oophoritis, unspecified |
| GA0Z | Inflammatory diseases of female genital tract, unspecified |
| GB21.Z | Inflammatory diseases of the breast, unspecified |
| GB50 | Acute tubulo-interstitial nephritis |
| GB51 | Acute pyelonephritis |
| GB55.Z | Chronic tubulo-interstitial nephritis, unspecified |
| GB5Z | Renal tubulo-interstitial diseases, unspecified |
| GC00.Z | Cystitis, unspecified |
| GC02.Z | Urethritis and urethral syndrome, unspecified |
| JB45.Z | Infections of the breast associated with childbirth, unspecified |
| KA60 | Fetal or neonatal sepsis |
| KA65.0 | Conjunctivitis or dacryocystitis of newborn |
| KA65.1 | Omphalitis of newborn |
| KA6Z | Infections of fetus or newborn, unspecified |
| NE11 | Burn of unspecified body region |
| NF0A.3 | Posttraumatic wound infection, not elsewhere classified |
| XN2QM | Gram-positive bacteria |
| XN3NM | Streptococcus |
| XN9ZG | Staphylococcus |
| GA0Z | Inflammatory diseases of female genital tract, unspecified |
| XA5WW1 | Cervix uteri |
Dosage Regimen
| The method of application and dosage regimen for a specific drug depend on its form of release and other factors. The optimal dosage regimen is determined by the doctor. It is necessary to strictly adhere to the compliance of the dosage form of a specific drug with the indications for use and dosage regimen. |
Administer orally, rectally, topically, or via irrigation. Introduce into wound cavities, nasal passages, sinuses, uterus, vagina, or other drained body spaces.
Determine the dosage based on the patient’s age and the clinical application method. Confirm pathogen susceptibility to the bacteriophage prior to initiating therapy.
For oral administration, take on an empty stomach, 1-2 hours before a meal. For rectal use, administer as an enema after bowel evacuation.
Treat purulent wounds, burns, and infected skin lesions by irrigation and application of a moist gauze dressing soaked in the solution. Introduce into wound cavities, abscesses, and body spaces after pus removal.
In gynecological practice, administer intravaginally or intrauterinely. For otorhinolaryngological conditions, instill into the nose, sinuses, or use for gargling.
For intestinal forms and dysbiosis, use orally and/or rectally. In neonatal practice, apply orally, rectally, or use for irrigation of mucous membranes and wound surfaces.
Adverse Reactions
Not established.
Contraindications
Hypersensitivity to this agent.
Use in Pregnancy and Lactation
The use of this agent during pregnancy and breastfeeding is possible in the presence of infections caused by phage-sensitive strains of streptococci (as recommended by a doctor).
Pediatric Use
It is used according to indications in accordance with the dosage regimen.
Special Precautions
An important condition for effective phage therapy is the preliminary determination of the phage sensitivity of the pathogen.
Drug Interactions
The use of the bacteriophage does not exclude the use of other antibacterial drugs.
Storage Conditions
Store at 2°C (36°F) to 8°C (46°F). Keep in original packaging, protected from light. Keep out of reach of children.
Dispensing Status
Over-the-Counter
Important Safety Information
This information is for educational purposes only and does not replace professional medical advice. Always consult your doctor before use. Dosage and side effects may vary. Use only as prescribed.
Medical Disclaimer
Cerebrolysin, solution for injection 2ml ampoules 10pcs
Kagocel pills 12mg, 30pcs
Phenibut-Vertex pills 250mg, 20pcs
Belosalic, lotion solution for external use spray 100ml
Noopept, pills 10mg, 50pcs
OKI, sachets 80mg 2g, 12pcs
Mildronate capsules 500mg, 90pcs
Fenotropil pills 100mg, 60pcs
Belosalic, ointment, 30g
Daivobet, ointment, 30g
Cavinton Comfort, dispersible pills 10mg 90pcs
Cortexin, 10mg, 5ml, 10pcs
Actovegin pills 200mg, 50pcs
Nootropil pills 800mg, 30pcs
No-spa pills 40mg, 64pcs
Arbidol, capsules 100mg, 40pcs
Ingavirin capsules 90mg, 10pcs
Picamilon pills 50mg, 60pcs 